Pages that link to "Q41822143"
Jump to navigation
Jump to search
The following pages link to Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. (Q41822143):
Displaying 42 items.
- PPARγ and the Innate Immune System Mediate the Resolution of Inflammation (Q26771755) (← links)
- Peroxisome proliferator-activated receptors gamma ligands and ischemia and reperfusion injury (Q28302597) (← links)
- Redox regulation of soluble epoxide hydrolase by 15-deoxy-delta-prostaglandin J2 controls coronary hypoxic vasodilation (Q28395654) (← links)
- Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shock (Q28575608) (← links)
- Differential induction of PPAR-gamma by luminal glutamine and iNOS by luminal arginine in the rodent postischemic small bowel (Q28583062) (← links)
- Extension of the neuroprotective time window for thiazolidinediones in ischemic stroke is dependent on time of reperfusion (Q34126249) (← links)
- Gastrointestinal Cytoprotection by PPAR Ligands (Q34159427) (← links)
- 15-Deoxy-Δ12,14-prostaglandin J2, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling (Q34208174) (← links)
- Involvement of PPAR nuclear receptors in tissue injury and wound repair (Q34416422) (← links)
- Effects of rosiglitazone on the configuration of action potentials and ion currents in canine ventricular cells (Q35005663) (← links)
- PPARgamma as a new therapeutic target in inflammatory bowel diseases (Q35768913) (← links)
- New insights into the role of peroxisome proliferator-activated receptors in regulating the inflammatory response after tissue injury (Q35864188) (← links)
- Protective effect of peroxisome proliferator activated receptor gamma agonists on diabetic and non-diabetic renal diseases (Q36262404) (← links)
- Rosiglitazone protects against severe hemorrhagic shock-induced organ damage in rats. (Q36516240) (← links)
- Nutrigenomics: concepts and applications to pharmacogenomics and clinical medicine (Q36772839) (← links)
- Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury (Q36774010) (← links)
- 15-deoxy-delta12,14-prostaglandin J2 attenuates endothelial-monocyte interaction: implication for inflammatory diseases (Q36865438) (← links)
- Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review (Q37014196) (← links)
- PPARs Mediate Lipid Signaling in Inflammation and Cancer (Q37021709) (← links)
- Peroxisome proliferator activated receptor gamma and oxidized docosahexaenoic acids as new class of ligand (Q37056369) (← links)
- Rosiglitazone attenuates the severity of hyperlipidemic severe acute pancreatitis in rats (Q37231249) (← links)
- The possible role of peroxisome proliferator-activated receptor gamma in heart failure. (Q37277818) (← links)
- Niacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia (Q37376937) (← links)
- Albumin-binding and tumor vasculature determine the antitumor effect of 15-deoxy-Delta-(12,14)-prostaglandin-J(2) in vivo (Q37478648) (← links)
- Management of cardiac fibrosis in diabetic rats; the role of peroxisome proliferator activated receptor gamma (PPAR-gamma) and calcium channel blockers (CCBs) (Q39766035) (← links)
- Ligands of the peroxisome proliferator-activated receptor-gamma and heart failure (Q42027743) (← links)
- PPARγ in Inflammatory Bowel Disease (Q42038488) (← links)
- A PPAR-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J(2), inhibited gastric mucosal injury induced by ischemia-reperfusion in rats (Q42474531) (← links)
- Ligands of the peroxisome proliferator-activated receptor-gamma and heart failure (Q43262336) (← links)
- Significance of rosiglitazone inhibiting TLR4 expression in partial hepatic ischemia/reperfusion of mice (Q46322333) (← links)
- The cyclopentenone prostaglandin 15-deoxydelta(12,14)-prostaglandin J2 attenuates the development of zymosan-induced shock (Q46469543) (← links)
- Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia-reperfusion injury in mice with metabolic disorders (Q46627323) (← links)
- 15-deoxy-Delta12,14-prostaglandin J2 attenuates development of cyclophosphamide-induced cystitis in rats (Q46930348) (← links)
- Tyrphostin AG 126 reduces intestinal ischemia-reperfusion injury in the rat. (Q46950214) (← links)
- Effects of 15-deoxy-Delta12,14-prostaglandin-J2 during hyperdynamic porcine endotoxemia. (Q46988945) (← links)
- Protective influence of rosiglitazone against testicular ischaemia-reperfusion injury in rats (Q48282339) (← links)
- Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone (Q48617615) (← links)
- Association between Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma 2 and myocardial infarction in the Chinese Han population (Q51493325) (← links)
- Rosiglitazone, an agonist of peroxisome proliferator-activated receptor-gamma, prevents contralateral testicular ischaemia-reperfusion injury in prepubertal rats. (Q53559064) (← links)
- Prepartum body conditions affect insulin signaling pathways in postpartum adipose tissues in transition dairy cows (Q64054570) (← links)
- Role of PPARγ in the salutary effects of 17β‐estradiol on kupffer cell cytokine production following trauma‐hemorrhage (Q84604261) (← links)
- Carbon monoxide-releasing molecule-3: Amelioration of renal ischemia reperfusion injury in a rat model (Q97527540) (← links)